Resolution of Hereditary Hemorrhagic Telangiectasia and Anemia with Prolonged α-interferon Therapy for Chronic Hepatitis C

Omar I. Massoud, Wael I. Youssef, Kevin D. Mullen

Research output: Contribution to journalArticlepeer-review

Abstract

Hereditary hemorrhagic telangiectasia is a group of autosomal dominant disorders, characterized by telangiectases that develop in the skin, mucous membranes, and visceral organs. Currently, there is no satisfactory treatment of hereditary hemorrhagic telangiectasia. Interferon has never been used for the treatment of hereditary hemorrhagic telangiectasia. In this case, we report disappearance of hereditary hemorrhagic telangiectasia lesions after 12 months of treatment with interferon-α for chronic hepatitis C. Further studies are warranted to evaluate its role and potential use in the treatment of hereditary hemorrhagic telangiectasia.

Original languageEnglish (US)
Pages (from-to)377-379
Number of pages3
JournalJournal of Clinical Gastroenterology
Volume38
Issue number4
DOIs
StatePublished - Apr 1 2004
Externally publishedYes

Keywords

  • Anemia
  • Hepatitis C
  • Hereditary hemorrhagic telangiectasia
  • Interferon-α

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Resolution of Hereditary Hemorrhagic Telangiectasia and Anemia with Prolonged α-interferon Therapy for Chronic Hepatitis C'. Together they form a unique fingerprint.

Cite this